If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Director/PDMR Shareholding

1 Sep 2016 07:00

RNS Number : 6240I
Lakehouse plc
01 September 2016
 

LAKEHOUSE PLC

 

 

DIRECTOR/PDMR SHAREHOLDING

Released: 1 September 2016

 

 

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Robert Holt

2.

Reason for the notification

(a)

Position/status

Executive Chairman (PDMR)

(b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Lakehouse plc

(b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument

An option to acquire ordinary shares of 10p each in the capital of Lakehouse plc ("Shares")

 

Identification code

GB00BSKS1M86

(b)

Nature of the transaction

Grant of an award structured as a nil-cost option (with zero exercise price per Share) over 2,307,692 Shares ("Award"), under, and subject to, the terms of the Lakehouse plc Special Incentive Award Plan ("Plan"). The number of Shares in respect of which the Award may ultimately be exercised will be dependent upon the extent to which the performance conditions set out in the Plan are satisfied but in all circumstances cannot exceed 4,615,384 Shares (maximum vesting if the performance conditions are met in full). The Award will normally become capable of exercise on the day after the first to occur of: (i) 31 January 2019; or (ii) the date that the audited financial results for the Financial Year ending 30 September 2018 are published ("Vesting Date") and will cease to be capable of exercise (and lapse) on the day immediately before second anniversary of such Vesting Date.

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil per Share

2,307,692

(d)

Aggregated information

N/A - single transaction

(e)

Date of transaction

31 August 2016

(f)

Place of transaction

United Kingdom

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAXPFDDEKEFF
Date   Source Headline
28th Jan 20213:07 pmRNSHolding(s) in Company
23rd Dec 20202:34 pmRNSBulletin Board Correction
23rd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 202012:13 pmRNSNotice of Preliminary Results
16th Nov 202011:15 amRNSNotification of Major Holdings
16th Nov 202011:13 amRNSGrant and vesting of awards
13th Nov 20209:12 amRNSExercise of Options and Total Voting Rights
3rd Nov 20204:58 pmRNSHolding(s) in Company
2nd Nov 202010:43 amRNSNotification of Major Holdings
14th Oct 202010:53 amRNSExercise of Options and Total Voting Rights
13th Oct 20201:07 pmRNSHolding(s) in Company
6th Oct 202012:07 pmRNSExercise of Options and Total Voting Rights
6th Oct 20207:00 amRNSPost year-end trading update
7th Sep 20209:47 amRNSExercise of Options and Total Voting Rights
4th Sep 20209:40 amRNSTransaction by Directors / PDMR
1st Sep 20203:25 pmRNSHolding(s) in Company
19th Aug 20207:00 amRNSTrading Update: Delivering a strong performance
13th Aug 20209:10 amRNSExercise of Options and Total Voting Rights
3rd Jul 20203:14 pmRNSExercise of Options and Total Voting Rights
16th Jun 20202:32 pmRNSExercise of Options and Total Voting Rights
8th Jun 20203:02 pmRNSExercise of options and admission to trading
27th May 20207:00 amRNSInterim Results
21st May 20207:00 amRNSExercise of options and admission to trading
7th May 20207:00 amRNSExercise of options and admission to trading
30th Mar 20207:00 amRNSCOVID-19 Update and Dividend Payment Confirmation
18th Mar 202010:46 amRNSResult of AGM
18th Mar 20207:00 amRNSAGM Statement
20th Feb 20207:00 amRNSPosting of Annual Report and Notice of AGM
20th Feb 20207:00 amRNSPosting of Annual Report and Notice of AGM
21st Jan 20207:00 amRNSPreliminary Results
25th Nov 20195:15 pmRNSDirector Dealing
23rd Oct 20197:00 amRNSNet debt position
4th Oct 20197:00 amRNSPost year end trading update and Board changes
25th Jun 20197:00 amRNSDirectorate change
25th Jun 20197:00 amRNSInterim Results for the six months ended 31 March
24th Jun 20192:41 pmRNSChange of Adviser
24th Jun 201911:29 amRNSDirectors' disclosures
21st May 201912:44 pmRNSDirector/PDMR Shareholding
21st May 20197:00 amRNSHolding(s) in Company
16th May 20192:30 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSChange of Registered Office
15th Apr 20197:00 amRNSExercise of options
19th Mar 20191:26 pmRNSDirector Disclosure
19th Mar 201911:08 amRNSResults of AGM
18th Mar 201912:14 pmRNSDirectorate Change
12th Mar 201911:38 amRNSHolding(s) in Company
7th Mar 20192:25 pmRNSHolding(s) in Company
21st Feb 20197:00 amRNSPosting of Annual Report and Notice of AGM
22nd Jan 20197:00 amRNSPreliminary Results
9th Jan 20194:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.